EUA

InteliSwab COVID-19 Rapid Test Rx

FDA Emergency Use Authorization · OraSure Technologies, Inc. · Sep 26, 2023

Key facts

Product InteliSwab COVID-19 Rapid Test Rx
Company OraSure Technologies, Inc.
Product type Lateral Flow, Visual Read, Prescription Home Testing, Single Target
Date Sep 26, 2023
FDA page fda.gov

At a glance

  • 1–9 Authorization documents
  • 1–9 EUAs for this company

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Emergency Use Authorizations

Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.

Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date:

Browse all Emergency Use Authorizations